Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Rikke B Soerensen
HLA-A24 and Survivin: Possibilities in Therapeutic Vaccination Against Cancer
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Related publications
Randomized Phase II Trial of Survivin 2B Peptide Vaccination for Patients With HLA-A24-positive Pancreatic Adenocarcinoma
Cancer Science
Cancer Research
Medicine
Oncology
Therapeutic Cancer Vaccines and Combination Immunotherapies Involving Vaccination
ImmunoTargets and Therapy
Allergy
Immunology
Therapeutic Vaccination Against Autologous Cancer Stem Cells With mRNA-transfected Dendritic Cells in Patients With Glioblastoma
Cancer Immunology, Immunotherapy
Cancer Research
Medicine
Oncology
Allergy
Immunology
The Delivery of Effective Therapeutic Cancer Vaccination
Asian Journal of Andrology
Medicine
Urology
Identification of Squamous Cell Carcinoma Antigen-Derived Peptides Having the Capacity of Inducing Cancer-Reactive CTLs in HLA-A24+ Cancer Patients
International Journal of Oncology
Cancer Research
Oncology
Identification of a Novel HLA-A24-restricted Cytotoxic T Lymphocyte Epitope Peptide Derived From Mesothelin in Pancreatic Cancer
Oncotarget
Oncology
XIAP and Survivin as Therapeutic Targets for Radiation Sensitization in Preclinical Models of Lung Cancer
Oncogene
Cancer Research
Genetics
Molecular Biology
Treg Inducing Adjuvants for Therapeutic Vaccination Against Chronic Inflammatory Diseases
Frontiers in Immunology
Allergy
Immunology
Delivery of a Survivin Promoter-Driven Antisense Survivin-Expressing Plasmid DNA as a Cancer Therapeutic: A Proof-Of-Concept Study
OncoTargets and Therapy
Oncology
Pharmacology